Skip to main content

Genitourinary System Cancers

  • Chapter
  • First Online:
Basic Radiation Oncology

Abstract

Prostate cancer is the most common cancer in men and the second most common cause of cancer-related mortality in males [1]. Ninety-five percent of prostate cancer cases are diagnosed between 45 and 89 years of age (mean: 72 years). The incidence of prostate cancer increases with age, and the risk of developing it is 1/10,000 before 40 years of age, 1/103 between 40 and 59 years of age, 1/8 between 60 and 79 years of age [2]. The risk of prostate cancer in a man over the course of his lifetime is nearly 10%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garnick MB (1993) Prostate cancer: screening, diagnosis, and management. Ann Intern Med 118(10):804–818

    PubMed  CAS  Google Scholar 

  2. American Cancer Society (2008) American Cancer Society: cancer facts and figures 2008. American Cancer Society, Atlanta, GA

    Google Scholar 

  3. Augustin H, Erbersdobler A, Hammerer PG, Graefen M, Huland H (2004) Prostate cancers in the transition zone: part 2; clinical aspects. BJU Int 94(9):1226–1229 (review)

    Article  PubMed  Google Scholar 

  4. Kurokawa K, Suzuki T, SuzukI K, Terada N, Ito K, Yoshikawa D, Arai Y, Yamanaka H (2003) Preliminary results of a monitoring system to confirm the preservation of cavernous nerves. Int J Urol 10(3):136–140

    Article  PubMed  Google Scholar 

  5. Ali M, Johnson IP, Hobson J, Mohammadi B, Khan F (2004) Anatomy of the pelvic plexus and innervation of the prostate gland. Clin Anat 17(2):123–129

    Article  PubMed  CAS  Google Scholar 

  6. Algaba F, Epstein JI, Aldape HC et al (1996) Assessment of prostate carcinoma in core needle biopsy–definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer 78(2):376–381

    Article  PubMed  CAS  Google Scholar 

  7. Konishi N, Shimada K, Ishida E, Nakamura M (2005) Molecular pathology of prostate cancer. Pathol Int 55(9):531–539 (review)

    Article  PubMed  CAS  Google Scholar 

  8. Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, PA, pp 171–197

    Google Scholar 

  9. Reynolds MA, Kastury K, Groskopf J, Schalken JA, Rittenhouse H (2007) Molecular markers for prostate cancer. Cancer Lett 249(1):5–13 (review)

    Google Scholar 

  10. Presti JR (2000) Neoplasm of the prostate gland. In: Tanagho EA, McAninch JW (eds) Smith’s general urology, 15th edn. McGraw-Hill, San Francisco, pp 399–421

    Google Scholar 

  11. Akyol F, Ozyigit G, Selek U, Karabulut E (2005) PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol 48:40–45

    Article  PubMed  CAS  Google Scholar 

  12. AJCC (2010) Prostate. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 457

    Google Scholar 

  13. Kiyoshima K, Yokomizo A, Yoshida T, Tomita K, Yonemasu H, Nakamura M, Oda Y, Naito S, Hasegawa Y (2004) Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. Jpn J Clin Oncol 34(8):463–468

    Article  PubMed  Google Scholar 

  14. Woods ME, Ouwenga M, Quek ML (2007) The role of pelvic lymphadenectomy in the management of prostate and bladder cancer. ScientificWorldJournal 7:789–799 (review)

    Article  PubMed  Google Scholar 

  15. Coleman RE (2007) Emerging strategies in bone health management for the adjuvant patient. Semin Oncol 34(6 suppl 4):S11–S16 (review)

    Article  PubMed  CAS  Google Scholar 

  16. Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, pp 297–298

    Google Scholar 

  17. Grubb RL III, Vardi IY, Bhayani SB, Kibel AS (2006) Minimally invasive approaches to localized prostate carcinoma. Hematol Oncol Clin North Am 20(4):879–895. (review)

    Article  PubMed  Google Scholar 

  18. Villavicencio H, Segarra J (2006) Perineal prostatectomy. Ann Urol (Paris) 40(5):317–327 (review)

    Article  CAS  Google Scholar 

  19. Roach M III (2003) Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long? J Urol 170(6 pt 2):S35–S40; discussion S40–S41 (review)

    Google Scholar 

  20. Khan FM (2007) Treatment planning in radiation oncology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, p 128

    Google Scholar 

  21. Fiks T, Sporny S (1985) Klinefelter’s syndrome and neoplasms. Wiad Lek 38(17):1223–1226 (review)

    PubMed  CAS  Google Scholar 

  22. Woodward PJ, Heidenreich A, Looijenga LHJ et al (2004) Germ cell tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, France, pp 221–249

    Google Scholar 

  23. Bosl GJ, Bajorin DF, Sheinfeld J et al (2005) Cancer of the testis. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1269–1290

    Google Scholar 

  24. Segal R, Lukka H, Klotz LH, Eady A, Bestic N, Johnston M; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group (2001) Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline. Can J Urol 8(1):1184–1192 (review)

    PubMed  CAS  Google Scholar 

  25. AJCC (2010) Testis. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 469

    Google Scholar 

  26. Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, p 328

    Google Scholar 

  27. Shabbir M, Morgan RJ (2004) Testicular cancer. J R Soc Health 124(5):217–218 (review)

    Article  Google Scholar 

  28. Naysmith TE, Blake DA, Harvey VJ, Johnson NP (1998) Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod 13(11):3250–3255

    Article  PubMed  CAS  Google Scholar 

  29. Madeb R, Golijanin D, Knopf J, Messing EM (2007) Current state of screening for bladder cancer. Expert Rev Anticancer Ther 7(7):981–987 (review)

    Article  PubMed  Google Scholar 

  30. Mostofi FK, Davis CJ, Sesterhenn IA (1988) Pathology of tumors of the urinary tract. In: Skinner DG, Lieskovsky G (eds) Diagnosis and management of genitourinary cancer. WB Saunders, Philadelphia, PA, pp 83–117

    Google Scholar 

  31. AJCC (2010) Urinary bladder. In: Edge SB, et al. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, p 497

    Google Scholar 

  32. Soloway MS (1983) The management of superficial bladder cancer. In: Javadpour N (ed) Principles and management of urologic cancer, 2nd edn. Williams and Wilkins, Baltimore, MD, pp 446–467

    Google Scholar 

  33. Epstein JI (2003) The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement? Crit Rev Oncol Hematol 47(2):83–89 (review)

    Article  PubMed  Google Scholar 

  34. Hansen EK, Roach M III (2006) Handbook of evidence-based radiation oncology. Springer, US, pp 286–287

    Google Scholar 

  35. Schulsinger AR, Allison RR, Choi WH (2006) Bladder cancer. In: Levitt SH, Purdy JA, Perez CA, Vijayakumar S (eds) Technical basis of radiation therapy. Springer, New York, pp 574–575

    Google Scholar 

  36. Levitt SH, Purdy JA, Perez CA (2006) Technical basis of radiation therapy, 4th revised edition. Springer, Berlin

    Book  Google Scholar 

  37. Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer: AJCC cancer staging manual, 6th edn. Springer, New York

    Google Scholar 

  38. Hofker MH, van Deursen J (2002) Transgenic Mouse: Methods and Protocols, 1st edition, Humana Press, New Jersey

    Book  Google Scholar 

  39. Pearse M, Morton GJ (2006) Testicular cancer. In: Perez C, Vijayakumar S (eds) Technical basis of radiation therapy, 4th revised edition. Springer, Berlin

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gokhan Ozyigit .

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ozyigit, G., Beyzadeoglu, M., Ebruli, C. (2010). Genitourinary System Cancers. In: Basic Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11666-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11666-7_8

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11665-0

  • Online ISBN: 978-3-642-11666-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics